Stock 600223 LUSHANG FREDA PHARMACEUTICAL CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Lushang Freda Pharmaceutical Co.,Ltd.

Equities

600223

CNE000001147

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
7.89 CNY -5.96% Intraday chart for Lushang Freda Pharmaceutical Co.,Ltd. -3.07% -18.07%
Apr. 29 Lushang Freda Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Mar. 21 Lushang Freda Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 8,438 8,595 13,371 10,765 9,790 8,021 - -
Enterprise Value (EV) 1 8,438 8,595 13,371 10,765 9,790 8,021 8,021 8,021
P/E ratio 24.8 x 13.5 x 37.9 x 265 x 32.1 x 21.2 x 16.4 x 13.7 x
Yield - - 0.83% - 1.04% 1.35% 1.71% 2%
Capitalization / Revenue - 0.63 x 1.08 x 0.83 x 2.14 x 1.69 x 1.44 x 1.26 x
EV / Revenue - 0.63 x 1.08 x 0.83 x 2.14 x 1.69 x 1.44 x 1.26 x
EV / EBITDA - 8.86 x 17.2 x 24.7 x 17.3 x 13.1 x 10.7 x 8.53 x
EV / FCF - - - 12.9 x 36.7 x 3.25 x 151 x 62.7 x
FCF Yield - - - 7.78% 2.72% 30.8% 0.66% 1.6%
Price to Book - 2.7 x 3.49 x 2.9 x 2.44 x 1.82 x 1.67 x 1.53 x
Nbr of stocks (in thousands) 1,000,968 1,008,831 1,009,152 1,016,569 1,016,569 1,016,569 - -
Reference price 2 8.430 8.520 13.25 10.59 9.630 7.890 7.890 7.890
Announcement Date 4/9/20 3/26/21 4/14/22 3/30/23 3/21/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 - 13,615 12,363 12,951 4,579 4,738 5,569 6,381
EBITDA 1 - 970.1 778.2 435.3 565.3 612.6 753 940.8
EBIT 1 - 875.4 677.7 310.8 419.4 517.6 667.7 808.2
Operating Margin - 6.43% 5.48% 2.4% 9.16% 10.92% 11.99% 12.67%
Earnings before Tax (EBT) 1 - 853.5 643.7 261.1 413 506.6 657.7 796.2
Net income 1 344.5 638.7 361.9 45.46 303.4 376.8 486.8 585.1
Net margin - 4.69% 2.93% 0.35% 6.63% 7.95% 8.74% 9.17%
EPS 2 0.3400 0.6300 0.3500 0.0400 0.3000 0.3722 0.4800 0.5750
Free Cash Flow 1 - - - 837.7 266.7 2,467 53 128
FCF margin - - - 6.47% 5.82% 52.07% 0.95% 2.01%
FCF Conversion (EBITDA) - - - 192.42% 47.17% 402.68% 7.04% 13.61%
FCF Conversion (Net income) - - - 1,842.87% 87.9% 654.72% 10.89% 21.88%
Dividend per Share 2 - - 0.1100 - 0.1000 0.1067 0.1350 0.1575
Announcement Date 4/9/20 3/26/21 4/14/22 3/30/23 3/21/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2023 Q1
Net sales -
EBITDA -
EBIT -
Operating Margin -
Earnings before Tax (EBT) -
Net income 1 129.3
Net margin -
EPS -
Dividend per Share -
Announcement Date 4/27/23
1CNY in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 - - - 838 267 2,467 53 128
ROE (net income / shareholders' equity) - 20% 8.34% 1.01% 7.56% 8.58% 10.1% 11.1%
ROA (Net income/ Total Assets) - - - - - 4.64% 5.52% 6.64%
Assets 1 - - - - - 8,121 8,819 8,815
Book Value Per Share 2 - 3.150 3.790 3.660 3.950 4.340 4.730 5.150
Cash Flow per Share 2 - 4.410 6.790 0.9800 0.4700 1.420 0.5500 1.270
Capex 1 - 156 281 160 207 209 247 277
Capex / Sales - 1.15% 2.27% 1.24% 4.53% 4.42% 4.44% 4.33%
Announcement Date 4/9/20 3/26/21 4/14/22 3/30/23 3/21/24 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Lushang Freda Pharmaceutical Co.,Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
7.89 CNY
Average target price
11.78 CNY
Spread / Average Target
+49.37%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
LUSHANG FREDA PHARMACEUTICAL CO.,LTD. Stock Lushang Freda Pharmaceutical Co.,Ltd.
-18.07% 1.11B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+21.85% 546B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.77% 359B
MERCK & CO., INC. Stock Merck & Co., Inc.
+16.97% 323B
ABBVIE INC. Stock AbbVie Inc.
+5.69% 290B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.68% 234B
NOVARTIS AG Stock Novartis AG
+3.65% 198B
ROCHE HOLDING AG Stock Roche Holding AG
-11.12% 194B
AMGEN INC. Stock Amgen Inc.
+8.08% 167B
PFIZER, INC. Stock Pfizer, Inc.
-3.40% 157B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 600223 Stock
  4. Financials Lushang Freda Pharmaceutical Co.,Ltd.